| SFRS10 |
SFRS10, TRA2B: Splicing factor, arginine/serine-rich 10 |
G3BP |
G3BP1, G3BP: Ras GTPase-activating protein-binding protein 1 |
0.435 |
Evidence |
|
| GNB1 |
GNB1: Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 |
CKAP1 |
TBCB, CG22, CKAP1: Tubulin folding cofactor B |
0.435 |
Evidence |
|
| RAP1A |
RAP1A, KREV1: Ras-related protein Rap-1A precursor |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
0.435 |
Evidence |
|
| RAP1B |
RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
0.435 |
Evidence |
|
| EIF3S9 |
EIF3S9: Eukaryotic translation initiation factor 3 subunit 9 |
G3BP |
G3BP1, G3BP: Ras GTPase-activating protein-binding protein 1 |
0.435 |
Evidence |
|
| FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
PABPN1 |
PABPN1, PAB2, PABP2: Polyadenylate-binding protein 2 |
0.435 |
Evidence |
|
| FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
HNRPF |
HNRPF: Heterogeneous nuclear ribonucleoprotein F |
0.435 |
Evidence |
|
| FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
SFRS1 |
SFRS1, ASF, OK/SW-cl.3, SF2, SF2P33: Splicing factor, arginine/serine-rich 1 |
0.435 |
Evidence |
|
| FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
PABPC4 |
PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 |
0.435 |
Evidence |
|
| FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
TIAL1 |
TIAL1: Nucleolysin TIAR |
0.435 |
Evidence |
|
| MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
ATAD2 |
ATAD2, L16, PRO2000: ATPase family AAA domain-containing protein 2 |
0.435 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
NACA |
NACA, HSD48: Nascent polypeptide-associated complex subunit alpha |
0.435 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
NEK9 |
NEK9, KIAA1995, NEK8, NERCC: Serine/threonine-protein kinase Nek9 |
0.435 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
0.435 |
Evidence |
|
| MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
ATAD2 |
ATAD2, L16, PRO2000: ATPase family AAA domain-containing protein 2 |
0.435 |
Evidence |
|
| MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
TRIP13 |
TRIP13: Thyroid receptor-interacting protein 13 |
0.435 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
NEK9 |
NEK9, KIAA1995, NEK8, NERCC: Serine/threonine-protein kinase Nek9 |
0.435 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
PSMD4 |
PSMD4, MCB1: 26S proteasome non-ATPase regulatory subunit 4 |
0.435 |
Evidence |
|
| DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
0.435 |
Evidence |
|
| PSMA5 |
PSMA5: Proteasome subunit alpha type-5 |
NEK9 |
NEK9, KIAA1995, NEK8, NERCC: Serine/threonine-protein kinase Nek9 |
0.435 |
Evidence |
|
| APEX1 |
APEX1, APE, APEX, APX, HAP1, REF1: DNA-(apurinic or apyrimidinic site) lyase |
CD2AP |
CD2AP: CD2-associated protein |
0.435 |
Evidence |
|
| MSN |
MSN: Moesin |
MYH9 |
MYH9: Myosin-9 |
0.435 |
Evidence |
|
| ITGB7 |
ITGB7: Integrin beta-7 precursor |
JAK1 |
|
0.435 |
Evidence |
|
| ITGB7 |
ITGB7: Integrin beta-7 precursor |
PRKD2 |
PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 |
0.435 |
Evidence |
|
| YY1 |
YY1: Transcriptional repressor protein YY1 |
DPF2 |
DPF2, REQ, UBID4: Zinc finger protein ubi-d4 |
0.435 |
Evidence |
|